Ultragenyx Pharmaceutical Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ultragenyx Pharmaceutical Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
  • Ultragenyx Pharmaceutical Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$134M, a 16.4% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$559M, a 12% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$607M, a 14.2% increase from 2022.
  • Ultragenyx Pharmaceutical Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$707M, a 55.8% decline from 2021.
  • Ultragenyx Pharmaceutical Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$454M, a 143% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$607M +$101M +14.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 -$707M -$253M -55.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 -$454M -$267M -143% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 -$187M +$216M +53.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 -$403M -$205M -104% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 -$198M +$105M +34.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-12
2017 -$302M -$56.3M -22.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-14
2016 -$246M -$100M -68.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-20
2015 -$146M -$85.8M -144% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-21
2014 -$59.8M -$24.7M -70.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 -$35.1M -$18.7M -115% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 -$16.3M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.